Adimmune Corp (Taiwan) Price on October 1, 2024

4142 Stock  TWD 20.70  0.55  2.59%   
If you're considering investing in Adimmune Stock, it is important to understand the factors that can impact its price. As of today, the current price of Adimmune Corp stands at 20.70, as last reported on the 13th of December 2024, with the highest price reaching 21.35 and the lowest price hitting 20.65 during the day. Adimmune Corp secures Sharpe Ratio (or Efficiency) of -0.37, which signifies that the company had a -0.37% return per unit of risk over the last 3 months. Adimmune Corp exposes twenty-two different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm Adimmune Corp's Standard Deviation of 1.13, mean deviation of 0.8456, and Risk Adjusted Performance of (0.26) to double-check the risk estimate we provide.
  
Adimmune Stock price history is provided at the adjusted basis, taking into account all of the recent filings.

Sharpe Ratio = -0.3749

Best PortfolioBest Equity
Good Returns
Average Returns
Small Returns
CashSmall RiskAverage RiskHigh RiskHuge Risk
Negative Returns4142

Estimated Market Risk

 1.14
  actual daily
10
90% of assets are more volatile

Expected Return

 -0.43
  actual daily
0
Most of other assets have higher returns

Risk-Adjusted Return

 -0.37
  actual daily
0
Most of other assets perform better
Based on monthly moving average Adimmune Corp is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Adimmune Corp by adding Adimmune Corp to a well-diversified portfolio.

Adimmune Corp Valuation on October 1, 2024

It is possible to determine the worth of Adimmune Corp on a given historical date. On October 1, 2024 Adimmune was worth 27.2 at the beginning of the trading date compared to the closed value of 27.35. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Adimmune Corp stock. Still, in general, we apply an absolute valuation method to find Adimmune Corp's value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Adimmune Corp where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Adimmune Corp's related companies.
 Open High Low Close Volume
  27.30    27.40    27.15    27.20    293,100  
10/01/2024
  27.20    27.40    27.10    27.35    272,781  
  27.35    27.35    27.35    27.35    1.00  
Backtest Adimmune Corp  |  Adimmune Corp History  |  Adimmune Corp Valuation   PreviousNext  
Open Value
27.2
27.35
Closing Value
30.62
Upside

Adimmune Corp Trading Date Momentum on October 1, 2024

On October 02 2024 Adimmune Corp was traded for  27.35  at the closing time. The highest price during the trading period was 27.35  and the lowest recorded bid was listed for  27.35 . There was no trading activity during the period 1.0. Lack of trading volume on October 2, 2024 did not affect price variability. The overall trading delta to the current price is 2.93% .

Adimmune Corp Fundamentals Correlations and Trends

By evaluating Adimmune Corp's financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Adimmune Corp's main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Adimmune financial account trend analysis is a perfect complement when working with valuation or volatility modules.

About Adimmune Corp Stock history

Adimmune Corp investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Adimmune is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Adimmune Corp will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Adimmune Corp stock prices may prove useful in developing a viable investing in Adimmune Corp
Adimmune Corporation manufactures and sells human vaccines in Taiwan. Adimmune Corporation was founded in 1965 and is based in Taichung City, Taiwan. ADIMMUNE CORPORATION operates under Biotechnology classification in Taiwan and is traded on Taiwan Stock Exchange. It employs 384 people.

Adimmune Corp Stock Technical Analysis

Adimmune Corp technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
A focus of Adimmune Corp technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Adimmune Corp trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...

Price Boundaries

Adimmune Corp Period Price Range

Low
December 13, 2024
0.00  NaN%
High

 0.00 

     

 0.00 

Adimmune Corp cannot be verified against its exchange. Please verify the symbol is currently traded on Taiwan Stock Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.

Adimmune Corp December 13, 2024 Market Strength

Market strength indicators help investors to evaluate how Adimmune Corp stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Adimmune Corp shares will generate the highest return on investment. By undertsting and applying Adimmune Corp stock market strength indicators, traders can identify Adimmune Corp entry and exit signals to maximize returns

Adimmune Corp Technical and Predictive Indicators

Predictive indicators are helping investors to find signals for Adimmune Corp's price direction in advance. Along with the technical and fundamental analysis of Adimmune Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Adimmune to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.

Additional Tools for Adimmune Stock Analysis

When running Adimmune Corp's price analysis, check to measure Adimmune Corp's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Adimmune Corp is operating at the current time. Most of Adimmune Corp's value examination focuses on studying past and present price action to predict the probability of Adimmune Corp's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Adimmune Corp's price. Additionally, you may evaluate how the addition of Adimmune Corp to your portfolios can decrease your overall portfolio volatility.